Answers are grounded in this paper and cite their sources.
Neuroinflammation is a critical driver of secondary thalamic damage after cortical infarction. The E3 ubiquitin ligase constitutive photomorphogenic 1 (COP1) has been known as an important negative regulator of the transcription factor CCAAT/enhancer-binding protein beta (c/EBPβ). However, the important role of COP1-c/EBPβ axis in secondary thalamic neuroinflammation after distal middle cerebral artery occlusion (dMCAO) remains unexplored. Herein, we investigated whether COP1 mitigates secondary thalamic neuroinflammation by ubiquitin-mediated degradation of c/EBPβ in microglia after dMCAO. Adult male Sprague-Dawley rats underwent Sham or dMCAO surgery. Inflammatory factors, c/EBPβ, COP1 and microglial polarization were assessed by transcriptomics, quantitative real-time polymerase chain reaction, western blotting, immunohistochemistry and single-cell RNA sequencing. short hairpin RNA and lentivirus were used to achieve c/EBPβ knockdown or overexpression and COP1 overexpression, respectively. K48-linked ubiquitination of c/EBPβ was examined. The neurological functions of rats were evaluated. We found that dMCAO triggered a pro-inflammatory milieu in the ipsilateral VPN, characterized by M1 microglial polarization and up-regulations of interleukin (IL)-1β, tumor necrosis factor-α (TNF-α) and inducible nitric oxide synthase (iNOS). What is worth noting that c/EBPβ was upregulated and shifted its expression from neurons to microglia, thus aggravating inflammation and neuronal loss in ipsilateral VPN after dMCAO. Nevertheless, with c/EBPβ knockdown the opposite results was observed. Crucially, COP1 expression was downregulated in ipsilateral VPN after dMCAO, while COP1 overexpression promoted K48-linked ubiquitination and degradation of c/EBPβ, thereby reducing microglial activation and pro-inflammatory cytokine release, and consequently conferring neuroprotection against secondary thalamic damage. Importantly, c/EBPβ re-expression reversed the protective effects of COP1 overexpression, manifested by increased IL-1β, TNF-α, and iNOS expressions, enhanced microglial activation, and aggravated neuronal damage and impaired neurological function. Our findings elucidate a previously unexplored mechanism by which COP1 alleviated secondary ipsilateral thalamic neuroinflammation after cortical infarction through ubiquitin-dependent degradation of c/EBPβ. Moreover, the restoration of c/EBPβ expression reversed the protection of COP1 overexpression. This study highlights the COP1-c/EBPβ axis as a promising therapeutic target for mitigating secondary thalamic damage after ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: